Change in rates of HBsAg and Anti-HBs in Sirnak 20 years after introduction of hepatitis B vaccine into routine infant immunization program

dc.authorid0000-0003-4147-3587
dc.contributor.authorŞahin, Meyha
dc.contributor.authorYazla, Meltem
dc.date.accessioned2024-03-01T09:22:23Z
dc.date.available2024-03-01T09:22:23Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı
dc.description.abstractObjectives: This study aimed to monitor the change in the rate of hepatitis B infections in Sirnak, a province in south-eastern Turkey, and to determine the rate of immunization for hepatitis B in this region after the national immunization program covered hepatitis B. Materials and Methods: This retrospective study included patients born in 1998 or after and applied to different outpatient clinics in the province between April 2017 and June 2018. Patients in this study were screened for HBsAg and anti-HBs for various reasons. We ana-lyzed confirmed HBsAg and anti-HBs positive results according to gender, age, and vertical transmission. Anti-HBs-positive patients were divided into four groups according to their ages, and the groups were compared. Results: Out of 2713 patients, 1530 (56.4%) were male, and the mean age was 12.77 (0-20). Four patients (0.14%) were HBsAg positive, and the anti-HBs positivity rate was 61.22%. The difference was statistically significant when the anti-HBs positivity rate was compared be-tween the age groups (p<0.001). The highest anti-HBs positivity rate was found in the 0 to 5 age group. Conclusion: There has been a significant decrease in hepatitis B virus infection rates after introducing the hepatitis B vaccine into routine infant immunization programs. The wide-spread introduction of hepatitis B vaccination should be targeted in Turkey, considering its geographical and sociocultural diversity.
dc.identifier.citationŞahin, M. ve Yazla, M. (2023). Change in rates of HBsAg and Anti-HBs in Sirnak 20 years after introduction of hepatitis B vaccine into routine infant immunization program. Infectious Diseases and Clinical Microbiology (Online), 5(2), 153-157. https://dx.doi.org/10.36519/idcm.2023.231
dc.identifier.doi10.36519/idcm.2023.231
dc.identifier.endpage157
dc.identifier.issn2667-646X
dc.identifier.issue2
dc.identifier.pmid38633007
dc.identifier.startpage153
dc.identifier.trdizinid1183925
dc.identifier.urihttps://dx.doi.org/10.36519/idcm.2023.231
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12334
dc.identifier.volume5
dc.identifier.wos001138794000011en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.institutionauthorŞahin, Meyha
dc.language.isoen
dc.publisherDoc Design and Informatics Co. Ltd.
dc.relation.ispartofInfectious Diseases and Clinical Microbiology (Online)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnti-HBs
dc.subjectHBsAg
dc.subjectVaccination
dc.titleChange in rates of HBsAg and Anti-HBs in Sirnak 20 years after introduction of hepatitis B vaccine into routine infant immunization program
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Sahin-Meyha-2023.pdf
Boyut:
110.93 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: